Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
Zheng Wang(Shanghai Jiao Tong University), Jian Zhou(Shenzhen University Health Science Center), Zhenggang Ren(Ministry of Education of the People's Republic of China), Shao‐Lai Zhou(Sun Yat-sen University), Xiaoyu Xu(Tsinghua University), Jie Hu(Zhongshan Hospital), Zhao–You Tang(Fudan University), Xin‐Rong Yang(Sun Yat-sen University), Xin Zhang(Fudan University), Yanhong Wang(Xuzhou Medical College), Yi Chen(Chinese Academy of Sciences), Jia Fan(Nanjing Tech University), Jiping Wang, Ao Huang(Beijing University of Civil Engineering and Architecture), W. Y. Lau(Chinese University of Hong Kong), Lei Yu(Taiyuan Central Hospital), Ningling Ge(Fudan University), Hui‐Chuan Sun(Fudan University)
Cited by 355
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644